OUH - Former Group Members

Former group members

Alejandra Paja García	Intern	B.Sc.
Haifeng Xu	PhD Student	M.Sc.
Jørgen Ankill	PhD Student	M.Sc.
Vandana Ravindran	Postdoctoral Researcher	PhD
Zhi Zhao	Postdoctoral Researcher	PhD
Anastasiia Brativnyk	Scientific Assistant	M.Sc.
Edgar Leal	Intern	B.Sc.
Kaja Børsum	M.Sc. Intern	B.Sc.
Anjana Bhat	M.Sc. Intern	B.Sc.
Tanguy Dumontier	Intern	M.Sc.
Laura Szekeres	Intern	B.Sc.

Scroll to top

Recent publications

Dechow A, Timonen S, Ianevski A, Jiang Q, Wahnschaffe L, Peng Y, Jungherz D, Becker K, Neubauer HA, Schönefeldt S, de Araujo E, Gunning P, Fleck R, Schrader A, Hallek M, Pflug N, Moriggl R, Aittokallio T, Mustjoki S, Braun T, Herling M (2025)
Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia
Leukemia (in press)
DOI 10.1038/s41375-025-02577-8, PubMed 40234614

Tanoli Z, Fernández-Torras A, Özcan UO, Kushnir A, Nader KM, Gadiya Y, Fiorenza L, Ianevski A, Vähä-Koskela M, Miihkinen M, Seemab U, Leinonen H, Seashore-Ludlow B, Tampere M, Kalman A, Ballante F, Benfenati E, Saunders G, Potdar S, Gómez García I, García-Serna R, Talarico C, Beccari AR, Schaal W, Polo A et al. (2025)
Computational drug repurposing: approaches, evaluation of in silico resources and case studies
Nat Rev Drug Discov (in press)
DOI 10.1038/s41573-025-01164-x, PubMed 40102635

Yin Y, Xu H, He L, Brown JR, Mato AR, Aittokallio T, Skånland SS (2025)
Protein profiles predict treatment responses to the PI3K inhibitor umbralisib in patients with chronic lymphocytic leukemia
Clin Cancer Res (in press)
DOI 10.1158/1078-0432.CCR-24-2911, PubMed 40085050